These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21228296)

  • 81. On the time-varying predictive performance of longitudinal biomarkers: Measure and estimation.
    Zhang J; Ning J; Huang X; Li R
    Stat Med; 2021 Oct; 40(23):5065-5077. PubMed ID: 34159633
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Antimicrobial Peptides (AMPs) in the Pathogenesis of Alzheimer's Disease: Implications for Diagnosis and Treatment.
    Bruno F; Malvaso A; Canterini S; Bruni AC
    Antibiotics (Basel); 2022 May; 11(6):. PubMed ID: 35740133
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Cognitive Reserve, Alzheimer's Neuropathology, and Risk of Dementia: A Systematic Review and Meta-Analysis.
    Nelson ME; Jester DJ; Petkus AJ; Andel R
    Neuropsychol Rev; 2021 Jun; 31(2):233-250. PubMed ID: 33415533
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cognitive Reserve from the Perspective of Preclinical Alzheimer Disease: 2020 Update.
    Soldan A; Pettigrew C; Albert M
    Clin Geriatr Med; 2020 May; 36(2):247-263. PubMed ID: 32222300
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Defining Cognitive Reserve and Implications for Cognitive Aging.
    Pettigrew C; Soldan A
    Curr Neurol Neurosci Rep; 2019 Jan; 19(1):1. PubMed ID: 30627880
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Hypertension and obesity moderate the relationship between β-amyloid and cognitive decline in midlife.
    Clark LR; Koscik RL; Allison SL; Berman SE; Norton D; Carlsson CM; Betthauser TJ; Bendlin BB; Christian BT; Chin NA; Asthana S; Johnson SC
    Alzheimers Dement; 2019 Mar; 15(3):418-428. PubMed ID: 30367828
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Evaluating Cognitive Reserve Through the Prism of Preclinical Alzheimer Disease.
    Soldan A; Pettigrew C; Albert M
    Psychiatr Clin North Am; 2018 Mar; 41(1):65-77. PubMed ID: 29412849
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Diagnosis of Alzheimer's disease in Brazil: Supplementary exams.
    Caramelli P; Teixeira AL; Buchpiguel CA; Lee HW; Livramento JA; Fernandez LL; Anghinah R;
    Dement Neuropsychol; 2011; 5(3):167-177. PubMed ID: 29213741
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin.
    Carro E; Bartolomé F; Bermejo-Pareja F; Villarejo-Galende A; Molina JA; Ortiz P; Calero M; Rabano A; Cantero JL; Orive G
    Alzheimers Dement (Amst); 2017; 8():131-138. PubMed ID: 28649597
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Biomarkers for the Early Detection and Progression of Alzheimer's Disease.
    Counts SE; Ikonomovic MD; Mercado N; Vega IE; Mufson EJ
    Neurotherapeutics; 2017 Jan; 14(1):35-53. PubMed ID: 27738903
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease.
    Ingber AP; Hassenstab J; Fagan AM; Benzinger TL; Grant EA; Holtzman DM; Morris JC; Roe CM
    J Alzheimers Dis; 2016; 52(3):1055-64. PubMed ID: 27104893
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Early diagnosis of Alzheimer's disease from elevated olfactory mucosal miR-206 level.
    Moon J; Lee ST; Kong IG; Byun JI; Sunwoo JS; Shin JW; Shim JY; Park JH; Jeon D; Jung KH; Jung KY; Kim DY; Lee SK; Kim M; Chu K
    Sci Rep; 2016 Feb; 6():20364. PubMed ID: 26842588
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Cerebrospinal Fluid proNGF: A Putative Biomarker for Early Alzheimer's Disease.
    Counts SE; He B; Prout JG; Michalski B; Farotti L; Fahnestock M; Mufson EJ
    Curr Alzheimer Res; 2016; 13(7):800-8. PubMed ID: 26825093
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Cognitive reserve and Aβ1-42 in mild cognitive impairment (Argentina-Alzheimer's Disease Neuroimaging Initiative).
    Harris P; Fernandez Suarez M; Surace EI; Chrem Méndez P; Martín ME; Clarens MF; Tapajóz F; Russo MJ; Campos J; Guinjoan SM; Sevlever G; Allegri RF
    Neuropsychiatr Dis Treat; 2015; 11():2599-604. PubMed ID: 26504392
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Cerebrospinal Fluid Biomarkers in Spinocerebellar Ataxia: A Pilot Study.
    Brouillette AM; Öz G; Gomez CM
    Dis Markers; 2015; 2015():413098. PubMed ID: 26265793
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Network Diffusion Model of Progression Predicts Longitudinal Patterns of Atrophy and Metabolism in Alzheimer's Disease.
    Raj A; LoCastro E; Kuceyeski A; Tosun D; Relkin N; Weiner M;
    Cell Rep; 2015 Jan; 10(3):359-369. PubMed ID: 25600871
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Plasma phospholipids identify antecedent memory impairment in older adults.
    Mapstone M; Cheema AK; Fiandaca MS; Zhong X; Mhyre TR; MacArthur LH; Hall WJ; Fisher SG; Peterson DR; Haley JM; Nazar MD; Rich SA; Berlau DJ; Peltz CB; Tan MT; Kawas CH; Federoff HJ
    Nat Med; 2014 Apr; 20(4):415-8. PubMed ID: 24608097
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease.
    Benzinger TL; Blazey T; Jack CR; Koeppe RA; Su Y; Xiong C; Raichle ME; Snyder AZ; Ances BM; Bateman RJ; Cairns NJ; Fagan AM; Goate A; Marcus DS; Aisen PS; Christensen JJ; Ercole L; Hornbeck RC; Farrar AM; Aldea P; Jasielec MS; Owen CJ; Xie X; Mayeux R; Brickman A; McDade E; Klunk W; Mathis CA; Ringman J; Thompson PM; Ghetti B; Saykin AJ; Sperling RA; Johnson KA; Salloway S; Correia S; Schofield PR; Masters CL; Rowe C; Villemagne VL; Martins R; Ourselin S; Rossor MN; Fox NC; Cash DM; Weiner MW; Holtzman DM; Buckles VD; Moulder K; Morris JC
    Proc Natl Acad Sci U S A; 2013 Nov; 110(47):E4502-9. PubMed ID: 24194552
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Relationship of cognitive reserve and cerebrospinal fluid biomarkers to the emergence of clinical symptoms in preclinical Alzheimer's disease.
    Soldan A; Pettigrew C; Li S; Wang MC; Moghekar A; Selnes OA; Albert M; O'Brien R;
    Neurobiol Aging; 2013 Dec; 34(12):2827-34. PubMed ID: 23916061
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later.
    Roe CM; Fagan AM; Grant EA; Hassenstab J; Moulder KL; Maue Dreyfus D; Sutphen CL; Benzinger TL; Mintun MA; Holtzman DM; Morris JC
    Neurology; 2013 May; 80(19):1784-91. PubMed ID: 23576620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.